Related references
Note: Only part of the references are listed.Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors
Huiping Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of Novel 17-Phenylethylaminegeldanamycin Derivatives as Potent Hsp90 Inhibitors
Zhenyu Li et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Cruentaren A Binds F1F0 ATP Synthase To Modulate the Hsp90 Protein Folding Machinery
Jessica A. Hall et al.
ACS CHEMICAL BIOLOGY (2014)
Development of radamide analogs as Grp94 inhibitors
Aaron Muth et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors
Zhenyu Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors
Zhenyu Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Alternative approaches to Hsp90 modulation for the treatment of cancer
Jessica A. Hall et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma
Andrew R. Stothert et al.
HUMAN MOLECULAR GENETICS (2014)
Microarray-based screening of heat shock protein inhibitors
Emilia Schax et al.
JOURNAL OF BIOTECHNOLOGY (2014)
Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors
Rohit Bhat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation
Cesar A. Perez et al.
LUNG CANCER (2014)
Selective targeting of the stress chaperome as a therapeutic strategy
Tony Taldone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors
M. A. Dickson et al.
ANNALS OF ONCOLOGY (2013)
Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
David S. Hong et al.
CANCER TREATMENT REVIEWS (2013)
An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors - potential therapeutics in cancer and neurodegeneration
Russell R. A. Kitson et al.
CHEMICAL COMMUNICATIONS (2013)
Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors
David Hong et al.
CLINICAL CANCER RESEARCH (2013)
Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma
Yunpeng Hua et al.
CLINICAL CANCER RESEARCH (2013)
The Therapeutic Target Hsp90 and Cancer Hallmarks
Yoshihiko Miyata et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis
Chaitanya A. Patwardhan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series
Tony Taldone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and Structure-Activity Relationships of EGCG Analogues, a Recently Identified Hsp90 Inhibitor
Anuj Khandelwal et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non-Small Cell Lung Cancer Growth
Edward B. Garon et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Inhibition of HSP90 molecular chaperones: moving into the clinic
Rocio Garcia-Carbonero et al.
LANCET ONCOLOGY (2013)
Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy
Jana Franke et al.
NATURAL PRODUCT REPORTS (2013)
21st Century natural product research and drug development and traditional medicines
Linh T. Ngo et al.
NATURAL PRODUCT REPORTS (2013)
Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2
Pallav D. Patel et al.
NATURE CHEMICAL BIOLOGY (2013)
Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway
Bei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The chaperone Hsp90: changing partners for demanding clients
Alina Roehl et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Structure, Function and Regulation of the Hsp90 Machinery
Johannes Buchner et al.
Biomedical Journal (2013)
HSP90 as a platform for the assembly of more effective cancer chemotherapy
Luke Whitesell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
Komal Jhaveri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
The 'active life' of Hsp90 complexes
Chrisostomos Prodromou
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones
Jing Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer
Takeshi Shimamura et al.
CLINICAL CANCER RESEARCH (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence
Nicolas Dejeans et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Glucose-regulated Protein 94 Triage of Mutant Myocilin through Endoplasmic Reticulum-associated Degradation Subverts a More Efficient Autophagic Clearance Mechanism
Amirthaa Suntharalingam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Charting, Navigating, and Populating Natural Product Chemical Space for Drug Discovery
Hugo Lachance et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Proteomic Plasma Membrane Profiling Reveals an Essential Role for gp96 in the Cell Surface Expression of LDLR Family Members, Including the LDL Receptor and LRP6
Michael P. Weekes et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Development of a Grp94 inhibitor
Adam S. Duerfeldt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Broad Substrate Specificity of the Amide Synthase in S. hygroscopicus-New 20-Membered Macrolactones Derived from Geldanamycin
Simone Eichner et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
Weiwen Ying et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking
Laura B. Peterson et al.
MOLECULAR PHARMACEUTICS (2012)
Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer
Tsuyoshi Ueno et al.
LUNG CANCER (2012)
Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90
Frank Wuest et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010
Samir Messaoudi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Targeting the Heat Shock Protein 90 Dimer with Dimeric Inhibitors
Bhaskar Reddy Kusuma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents
Huiping Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Learning from Falling: Retention of Fall-Resisting Behavior Derived from One Episode of Laboratory-Induced Slip Training
Tanvi Bhatt et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation, Tumor Shrinkage, and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors
Giuseppe Floris et al.
MOLECULAR CANCER THERAPEUTICS (2011)
A phase 1 study of IPI-504 (retaspimycin hydrochloride) in patients with relapsed or relapsed and refractory multiple myeloma
David Siegel et al.
LEUKEMIA & LYMPHOMA (2011)
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
Kamalika Moulick et al.
NATURE CHEMICAL BIOLOGY (2011)
New Molecular and Biological Mechanism of Antitumor Activities of KW-2478, a Novel Nonansamycin Heat Shock Protein 90 Inhibitor, in Multiple Myeloma Cells
Takayuki Nakashima et al.
CLINICAL CANCER RESEARCH (2010)
Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design
Andrew J. Woodhead et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90
Iwona E. Wrona et al.
JOURNAL OF ORGANIC CHEMISTRY (2010)
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Mikko Taipale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
GRP94 in ER quality control and stress responses
Davide Eletto et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Mechanistic Studies of Sansalvamide A-Amide: An Allosteric Modulator of Hsp90
Robert C. Vasko et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
(-)-Epigallocatechin-3-gallate Is a Novel Hsp90 Inhibitor
Zhengyu Yin et al.
BIOCHEMISTRY (2009)
Synthesis and evaluation of electron-rich curcumin analogues
Michael W. Amolins et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
New, Highly Active Nonbenzoquinone Geldanamycin Derivatives by Using Mutasynthesis
Simone Eichner et al.
CHEMBIOCHEM (2009)
Rational Biosynthetic Engineering for Optimization of Geldanamycin Analogues
Woncheol Kim et al.
CHEMBIOCHEM (2009)
Preparation, Modification, and Evaluation of Cruentaren A and Analogues
Martin Bindl et al.
CHEMISTRY-A EUROPEAN JOURNAL (2009)
Structure-Based and in silico Design of Hsp90 Inhibitors
Miriam Sgobba et al.
CHEMMEDCHEM (2009)
17 AAG for HSP90 Inhibition in Cancer - From Bench to Bedside
Saad Z. Usmani et al.
CURRENT MOLECULAR MEDICINE (2009)
Ansamycin Inhibitors of Hsp90: Nature's Prototype for Anti-Chaperone Therapy
James R. Porter et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases
Gary E. L. Brandt et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction
Tao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design
Robert M. Immormino et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Natural Product Inhibitors of Hsp90: Potential Leads for Drug Discovery
M. W. Amolins et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
Karen Lundgren et al.
MOLECULAR CANCER THERAPEUTICS (2009)
KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic Cells
Shary N. Shelton et al.
MOLECULAR PHARMACOLOGY (2009)
Design, Synthesis, and Biological Evaluation of Conformationally Constrained cis-Amide Hsp90 Inhibitors
Adam S. Duerfeldt et al.
ORGANIC LETTERS (2009)
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Jesse W. -H. Li et al.
SCIENCE (2009)
Synthesis and evaluation of 8,9-amido analogs of geldanamycin
Merritt B. Andrus et al.
TETRAHEDRON LETTERS (2009)
Synthesis and biological evaluation of cruentaren A analogues
Viktor V. Vintonyak et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Gedunin, a Novel Hsp90 inhibitor: Semisynthesis of Derivatives and Preliminary Structure-Activity Relationships
Gary E. L. Brandt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors
Ming-Qiang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Molecular characterization of macbecin as an Hsp90 inhibitor
Christine J. Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Natural products as leads to potential drugs: An old process or the new hope for drug discovery?
David J. Newman
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Tao Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
T. Stuehmer et al.
LEUKEMIA (2008)
Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites
Kyeong Lee et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Total synthesis of the Hsp90 inhibitor geldanamycin
Hua-Li Oin et al.
ORGANIC LETTERS (2008)
Mutasynthesis of geldanamycin by the disruption of a gene producing starter unit: Generation of structural diversity at the benzoquinone ring
Woncheol Kim et al.
CHEMBIOCHEM (2007)
Cruentaren A, a highly cytotoxic benzolactone from Myxobacteria is a novel selective inhibitor of mitochondrial F1-ATPases
Brigitte Kunze et al.
FEBS LETTERS (2007)
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity
Srinivas R. Kasibhatla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors
Swee Y. Sharp et al.
CANCER RESEARCH (2007)
Inhibition of Hsp90 with synthesis macrolactones: Synthesis and structural and biological evaluation of ring and conformational analogs of radicicol
Nicolas Proisy et al.
CHEMISTRY & BIOLOGY (2006)
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
Haley Hieronymus et al.
CANCER CELL (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90
Jie Ge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Dihydroquinone ansamycins: Toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives
AC Maroney et al.
BIOCHEMISTRY (2006)
Radanamycin, a macrocyclic chimera of radicicol and geldanamycin
MW Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Search for Hsp90 inhibitors with potential anticancer activity: Isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran Desert
TJ Turbyville et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90
HZ He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Concise synthesis of pochonin A, an HSP90 inhibitor
E Moulin et al.
ORGANIC LETTERS (2005)
The HSP90 family of genes in the human genome: Insights into their divergence and evolution
B Chen et al.
GENOMICS (2005)
Structure-based design of 7-carbamate analogs of geldanamycin
G Rastelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Solution- and solid-phase synthesis of radicicol (monorden) and pochonin C
S Barluenga et al.
CHEMISTRY-A EUROPEAN JOURNAL (2005)
The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors
KMJ Cheung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Radester, a novel inhibitor of the Hsp90 protein folding machinery
G Shen et al.
ORGANIC LETTERS (2005)
Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues
E Moulin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90
L Llauger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The evolving role of natural products in drug discovery
FE Koehn et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90
JY Le Brazidec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition
K Patel et al.
CHEMISTRY & BIOLOGY (2004)
The role of natural product chemistry in drug discovery
MS Butler
JOURNAL OF NATURAL PRODUCTS (2004)
Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide
RC Clevenger et al.
ORGANIC LETTERS (2004)
New efficient synthesis of resorcinylic macrolides via ynolides: Establishment of cycloproparadicicol as synthetically feasible preclinical anticancer agent based on Hsp90 as the target
ZQ Yang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Biotinylated geldanamycin
RC Clevenger et al.
JOURNAL OF ORGANIC CHEMISTRY (2004)
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms
L Wright et al.
CHEMISTRY & BIOLOGY (2004)
Targeting wide-range oncogenic transformation via PU24FCI, a specific inhibitor of tumor Hsp90
M Vilenchik et al.
CHEMISTRY & BIOLOGY (2004)
Synthesis and biological activities of novel 17-aminogeldanamycin derivatives
ZQ Tian et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Structure of the N-terminal domain of GRP94 - Basis for ligand specificity and regulation
KL Soldano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin:: Asymmetric glycolate aldol reactions and biological evaluation
MB Andrus et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Selective synthesis of the para-quinone region of geldanamycin
MB Andrus et al.
ORGANIC LETTERS (2003)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol
Y Ikuina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide affinity cleavage: a distinct nucleotide specificity of the C-terminal ATP-binding site
C Soti et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Total synthesis as a resource in the discovery of potentially valuable antitumor agents: Cycloproparadicicol
K Yamamoto et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Development of Radicicol Analogues
Shiro Soga et al.
CURRENT CANCER DRUG TARGETS (2003)
Structure and Functional Relationships of Hsp90
Chrisostomos Prodromou et al.
CURRENT CANCER DRUG TARGETS (2003)
Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase
G Chiosis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Halohydrin and oxime derivatives of radicicol: Synthesis and antitumor activities
T Agatsuma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin with use of asymmetric anti- and syn-glycolate aldol reactions
MB Andrus et al.
ORGANIC LETTERS (2002)
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2 Neu
WP Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Binding of ATP to heat shock protein 90 - Evidence for an ATP-binding site in the C-terminal domain
C Garnier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90 - N-terminal nucleotide binding unmasks a C-terminal binding pocket
C Soti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hsp90 inhibitors as novel cancer chemotherapeutic agents
L Neckers
TRENDS IN MOLECULAR MEDICINE (2002)
Concise asymmetric syntheses of radicicol and monocillin I
RM Garbaccio et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability
F Randow et al.
NATURE CELL BIOLOGY (2001)
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
G Chiosis et al.
CHEMISTRY & BIOLOGY (2001)
Synthesis of the left-hand portion of geldanamycin using an anti glycolate aldol reaction
MB Andrus et al.
ORGANIC LETTERS (2001)
The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone
MG Marcu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties
SJ Felts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins
MG Marcu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
